Terms & Conditions
Thank you for choosing Curia for your drug discovery, development and manufacturing needs.
We are committed to providing exemplary customer service and strive to ensure that the best performance and results are delivered at all of our sites around the world.
You can access the terms and conditions of our global services and solutions by clicking on the applicable link below.
**PLEASE BE INFORMED THAT CURIA RESERVES THE RIGHT, FROM TIME TO TIME, IN CURIA’S SOLE DISCRETION, TO AMEND ITS TERMS AND CONDITIONS. IT IS YOUR RESPONSIBILITY TO REVIEW AND FAMILIARIZE YOURSELF WITH THE TERMS AND CONDITIONS GOVERNING YOUR AGREEMENT, AND IT IS RECOMMENDED THAT YOU PRINT AND RETAIN A COPY OF SUCH TERMS AND CONDITIONS FOR YOUR RECORDS.
For Drug Discovery, Chemical Development and Analytical Services (“DDA”)
For agreements dated on or after 12/25/2023
DDA Terms and Conditions January 2024
For agreements dated on or after 4/25/2022
DDA Terms and Conditions April 2022
Analytical Services Portal Terms and Conditions July 2021
For agreements dated as of 7/12/2021 until 4/25/2022
DDA Terms and Conditions Sept 2021
Analytical Services Portal Terms and Conditions July 2021
For agreements dated as of 1/8/2019 until 7/12/2021
DDA Terms and Conditions
For agreements dated as of 8/25/2017 until 1/7/2019
DDA Terms and Conditions
For agreements dated before 8/25/2017
- Curia and/or its affiliates (with respect to discovery and development services)
- Albany Molecular Research Hyderabad Research Centre, Pvt. Ltd., AMRI India Pvt. Ltd. and/or Finekem
- Albany Molecular Research (UK) Ltd.
For the Manufacturing and Supply of Active Pharmaceutical Ingredients, Intermediates and/or Fine Chemicals (“API”)
For agreements dated on or after 4/25/2022
API Terms and Conditions April 2022
For agreements dated as of 7/12/2021 until 4/25/2022
API Terms and Conditions July 2021
For agreements dated as of 1/8/2019 until 7/12/2021
API Terms and Conditions
For agreements dated as of 8/25/2017 until 1/7/2019
API Terms and Conditions
For agreements dated before 8/25/2017
- Euticals SpA, Euticals, SAS, Euticals, GmbH and/or Chorisis S.r.L.
- Gadea Biopharma S.L. and/or Crystal Pharma S.A.
- AMRI Rensselaer, Inc., Euticals Inc., and/or Cedarburg Pharmaceuticals, Inc.
For the Development, Manufacturing and Supply of Drug Products (“DP”)
For agreements dated on or after 4/25/2022
DP Terms and Conditions April 2022
For agreements dated as of 7/12/2021 until 4/25/2022
DP Terms and Conditions July 2021
For agreements dated before 7/12/2021
DP Terms and Conditions
For the Development, Manufacturing and Supply of Biologics Drug Substance and Drug Product (“Biologics”)
For agreements dated on or after 8/14/2024
Biologics Terms and Conditions
India Corporate Governance
FY 2023-24
Corporate Social Responsibilities Policy
Corporate Social Responsibility Committee
Corporate Social Responsibility Projects
FY 2022-23
Corporate Social Responsibility Policy
Corporate Social Responsibility Committee
Corporate Social Responsibility Projects
Annual Return (Form MGT-7)
FY 2021-22
Corporate Social Responsibility Policy
Corporate Social Responsibility Committee
Corporate Social Responsibility Projects
Annual Return (Form MGT-7)
FY 2020-21
Corporate Social Responsibility Policy
Corporate Social Responsibility Committee
Corporate Social Responsibility Projects
Annual Return (Form MGT-7)
For additional information or to contact a customer service representative, please email: customerservice@curiaglobal.com